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Introduction: Deproteinized bovine bone mineral (Bio-Oss) is a xenogenic bone substitute,
widely used in maxillofacial bone regeneration. The aim of this in vitro study was to
investigate its influence on the growth behavior of human osteosarcoma cell line, Saos-2
culture, and compare it with the physiologic dose of Dexamethasone, an inductive factor for
osteoblasts. Materials and Methods: Human osteosarcoma cells, Saos-2, were cultured on Bio-
Oss and their growth rate was compared to Saos-2 cultures treated with Dexamethasone 10-7
M in contrast to cells cultivated in PBS, in the control group. Assessment of proliferation was
performed after 24, 36, and 48 hours by counting cells using trypan blue exclusion method.
Alkaline phosphatase was measured spectrophotometrically at 405 nm with paranitrophenol
buffer. Results: After 48 hours, the number of Saos-2 cells increased significantly when
subcultured with Bio-Oss. Bio-Oss was more effective on the enhancement of proliferation of
Saos-2 cells when compared to the physiologic dose of Dexamethasone (P<0.05). Alkaline
phosphatase activity increased in cells grown on Bio-Oss and dexamethasone 10-7M in
contrast to cells cultivated in PBS control group. The greatest level of activity was observed in
the group containing Bio-Oss after 48 hour. Conclusion: The significant increase of cell
proliferation and alkaline phosphatase activity in cells cultured on Bio-Oss, compared to
Dexamethasone-treated cells, suggests the important role of this bone substitute in promoting
bone regeneration.
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uring the past decades, the concept of utilizing a
combination of cells and signaling molecules to
activate/advance the passive effects of different
osteoconductive scaffolds and create an active bone
regeneration approach, has become central to dental
research [1].
The physical characteristics and chemical composition of
different scaffolds are thought to have significant influence on
cell behavior. Osteoblast-like cells seeded on different scaffolds
have demonstrated different proliferation, adhesion, and
differentiation abilities [2, 3]. Deproteinized bovine bone
mineral, a xenograft with osteoconductive properties, has
successfully promoted osteogenesis in different studies [4-7].
However, due to the lack of significant osteoinductive activity,
it is not a suitable replacement material to autogenous bone
graft, the gold standard for bone regeneration [8]. The effects
of deproteinized bovine bone mineral on proliferation and
differentiation of osteoblasts and osteoblast-like cells have
been evaluated in a few in vitro experiments. However, these
studies did not report comparable results [9-13].
The effect of various pharmacological agents on bone
healing and their possible co-application with tissue
engineering has received much attention in recent years [14,
15]. Dexamethasone (Dex) is a stimulating factor for
osteoblastic proliferation, differentiation, and matrix
mineralization in human pre-osteoblastic and osteoblastic
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0 100000±0.00 100000±0.00 100000±0.00
24 188000±32.11 188000±22.89 188000±42.78
36 233000±12.32 252000±12.97 298000±14.38
48 312000±35.47 328000±31.37 409333±30.76
Table 2. Alkaline phosphatase activity in Saos-2 cells
Tukey's multiple comparison test Mean Diff. P-value
C-48 vs Dex-7 -0.1375 P>0.05
C-48 vs BioOss-48 -0.8129 P<0.05
Dex-7 vs BioOss-48 -0.6754 P<0.05
cells [16, 17]. Furthermore, with a concentration range of10-8
-10-7 M [18], it can promote osteoblastic differentiation in
mesenchymal precursors and enhance expression of the
mature osteoblastic phenotype, in a time- and dose-
dependent manner [19].
The objective of this in vitro study was to assess the effect
of deproteinized bovine bone mineral on the growth and
differentiation of human osteosarcoma cell line, Saos-2,
and compare it with that of Dex in physiologic dose.
Material and Methods
Cell Culture
Human osteosarcoma cell line, Saos-2, was obtained from
National Cell Bank, Iran Pasture Institute (Tehran, Iran).
Saos-2 cells were cultured in a 75 cm2 flask containing RPMI
1640 supplemented with 10% fetal bovine serum (FBS)
(Gibco, Carlsbad, California, NY, USA), and 1% Penicillin-
Streptomycin (Gibco, Grand Island, NY, USA) were
incubated at 37°C with 5% CO2/95% air atmosphere. Medium
was changed every 3 days. Cells were dissociated with trypsin
and were subcultured every 4-5 days at a density of 1×104
cells/well in 24-well plates, in triplicate.
Determination of Cell Proliferation
The fourth passage of cells was used for this experimental
procedure. The 9 wells were divided into three groups; each
group had three wells: a control group that received
phosphate buffered saline (PBS), and two experimental
groups in which cells were directly exposed to three to five
granules of deproteinized bovine bone mineral (Bio-Oss,
Geistlich, Osteohealth Biomaterials, Bern, Switzerland), or
10-7 M of Dex (Sigma-Aldrich, Steinheim Germany). The
number of granules varied to ensure that the relative
amounts of each material were similar in each group. At the
indicated time intervals (24, 36, 48 hours), cells were
harvested and counted using trypan blue exclusion method.
The experiments were repeated three times.
Measuring Alkaline Phosphatase Activity
Alkaline phosphatase (ALP) activity of Saos-2 cells was
Figure 1. The growth curve of Saos-2 cells. The culture revealed a
significant increase in the number of viable cells after 2 days in the
group containing Bio-Oss
determined biochemically; this was used as an indicator of
osteoblastic phenotype activity. Saos-2 cells were cultured in
24 wells as described previously. After 24 and 48 hours of
incubation, the medium was removed and cells were
extracted by adding a lysis buffer containing 0.1% (v/v)
Triton X-100, 1 mM MgCl2, 0.1 mM ZnCl2 and 20 mM Tris
(pH=10, Merck, Darmstadt, Germany). This procedure was
performed by freezing at -70°C for 15 minutes and thawing at
37°C for 20 min, three times. For further disruption, the
cultures were frozen at -80°C and stored over night. The
enzyme activity was measured using paranitrophenol
phosphate in the diethanolamine buffer (Merck, Darmstadt
Germany) as substrate. The production of paranitrophenol
by ALP was detected spectrophotometrically at 405 nm. The
ALP activity results were expressed as UI/ (enzyme
activity)/10 4 cells.
Statistical Analysis
The data were analyzed using Mann–Whitney U followed by
Tukey-Kramer post-hoc test (SPSS 10.0, SPSS Inc., Chicago,
IL, USA). The level of significance was determined at P<0.05.
Results
Cell Proliferation
The proliferative effect of Bio-Oss and Dex on Saos-2 cells
was seen after 24, 36 and 48 hours, by means of trypan blue
exclusion method (Figure 1). The results from three
independentexperiments(n=3) were calculated and presented
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Figure 2. Alkaline phosphatase (ALP) activity of Saos-2 cells was
determined by spectrophotometric analysis at 24 h and 48 h time
points; BioOss group after 48 h revealed more activity than other
groups
as mean±standard error (SE) (Table 1). In the first 24 hours,
the rate of proliferation was comparable in the experimental
and control groups. After 36 hours, the difference between
Dex and control group was not yet significant (P>0.05) but
the number of cells and the rate of growth was significantly
higher in the Bio-Oss group (P<0.05). However, during the
36 to 48-hour period, the proliferation rate in experimental
groups altered in a way that at the end of evaluation time, the
number of Saos-2 cells was approximately similar in both
groups.
Alkaline Phosphatase Activity
The mean differences between ALP activity in control and
experimental groups were analyzed after 24 and 48 hour.
Both experimental groups had slightly more ALP activity
than the control group, after 24 hours (Figure 2). However,
after 48 hours, the phosphatase activity was significantly
higher in Bio-Oss group, compared to the others (P<0.05)
(Table 2), approximately 2 times greater than 48-hour
control group (Figure 3). The difference between 48-hour
Dex group and 48-hour control group was not statistically
significant (P>0.05) (Table 2).
Discussion
Bio-Oss is a biocompatible xenograft containing mineral
component of bovine bone, with the organic portion being
eliminated during particular procedures [8, 20, 21].
According to various histologic evaluations, the structural
properties of Bio-Oss, such as high porosity (75% to 80%) [5,
6, 22] as well as the presence of hydroxyapatite crystals are
comparable to those of human cancellous bone, provide
sufficient surface area for migration and adhesion of
osteogenic cells. This makes it feasible for the material to
integrate with the surrounding bone [1, 8, 9, 20, 21].
Stephan et al. proved that when cultured on an organic
bovine bone, osteoblastic cells can attach to the material (in a
30 to 60-min period) and proliferate [10]. Considering the
Figure 3. Spectrophotometry: Alkaline phosphatase (ALP)
expression between Bio-Oss scaffold and Dex (10-7 M) revealed that
ALP activity in the experimental groups was near to 1.5 times greater
than control groups
short time in which attachment occurred, they also suggested
that protein synthesis is not a prerequisite for cell
attachment. Acil et al. demonstrated similar results regarding
the attachment and proliferation of osteoblasts in their
investigation [9]. In contrast, Petrovic et al. showed a
decrease in proliferation of human osteoblast cells cultured
on Bio-Oss, however low cell density for initial seeding was
believed to be a limitation of this study [11]. The results of
the present study showed that Bio-Oss improves cell
proliferation as well as cell differentiation .
Various experiments have reported that the growth and
activity of osteoblasts cultured on Bio-Oss can be relatively
low comparing with other bone substitutes [2, 3, 11, 23, 24].
Despite these results, several clinical studies have approved
this technique, and showed successful results when the
material was applied as a bone substitute in implant
dentistry, sinus augmentation procedures and periodontal
regeneration [4-7]. Combining this xenograft with osteogenic
progenitor cells [9, 25] and/or specific growth factors will
compensate the lack of osteoinductivity to some extent [7].
In certain concentrations, dexamethasone is known to be
an inductive factor for osteoblastic cells and increases their
proliferation and differentiation [16, 17]. Moreover, it
stimulates mesenchymal stem cells to differentiate into the
osteogenic lineage [17, 19, 26]. Jaiswal et al. reported that 10-8
M Dex induces the highest ALP activity in human
mesenchymal stem cells, whereas the rate of mineral
deposition reached its maximum level at 10-7 M concentration
[18]. This enhancing effect not only reverses in higher
concentrations, but also is time- and species-dependant [19].
Jorgensen et al. demonstrated a significant increase in
proliferation and ALP activity of human bone marrow-
derived stromal cells that were treated with 10-7 M Dex for 7
days [17]. Eijken et al. used a human pre-osteoblast model to
assess the role of 10-7 M Dex during a 3 week period. They
showed a significant increase in cellular proliferation and
ALP activity. They also suggested that to effectively exploit
the beneficial effects of Dex, its application during the early
developmental stages is necessary [16].
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In a recent study, Song et al. successfully induced
ectopic bone formation by pretreatment of human
mesenchymal stem cells with 10-8 M Dex [27]. The required
treatment duration with Dex for attaining full osteogenic
differentiation was determined to be over 3 weeks. Guzman-
Morales and co-workers also confirmed previous studies’
results and introduced Dex (10-7 M or 10-8 M) as an inducing
factor for human bone marrow mesenchymal stem cells,
though with a collateral inhibitory effect on cell proliferation
[28]. One should notice that not all investigations have come
up with a unanimous conclusion and the effect of Dex on
osteoblastic proliferation and differentiation still remains
controversial [29]. The results of the present study indicated
that 10-7 M Dex slightly increased the proliferation rate and
the induced ALP activity was also lower than that in the Bio-
Oss group. While in most supporting studies, the enhancing
effect of Dex on cellular proliferation has been evaluated in
longer periods (weeks) [16, 17], our results indicate that
although, at the concentration of 10-7 M, Dex is less effective
than Bio-Oss in enhancing cellular proliferation, its effects
start within hours after addition to the culture.
Recently, some experiments have focused on the
addition of Dex to sustained releasing scaffolds, in order to
add an osteoinductive effect. In an in vitro study, Kim et al.
loaded PLGA scaffolds with ascorbate-2-phosphate and Dex,
so that a continuous release of these substances could be
obtained. The results showed significant calcium deposition
on the experimental cultures [26]. The subsequent in vivo
study also contributed to successful outcomes in osteogenesis
[30-33]. Although the current results do not demonstrate the
enhancing effect of Dex to be more than that of Bio-Oss,
further in vitro and in vivo studies need to be performed to
determine the feasibility and the efficacy of co-application of
Dex and Bio-Oss, as a novel method in tissue engineering.
Conclusion
According to the results of this in vitro study, in a 48 hours
evaluation period on Saos-2 cells, both Bio-Oss and 10-7 M
Dex increased the number of cells and the ALP activity.
However, the obtained increase in Dex-treated cells was not
statistically significant.
Conflict of Interest: ‘None declared’.
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